Found: 4
Select item for more details and to access through your institution.
OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3967, doi. 10.3390/cancers14163967
- By:
- Publication type:
- Article
Reaction of diethyl thiocyanatomethylphosphonate with aldehydes as a route to diethyl Z-1-alkenylphosphonates.
- Published in:
- Heteroatom Chemistry, 2007, v. 18, n. 7, p. 732, doi. 10.1002/hc.20371
- By:
- Publication type:
- Article
Stereochemical effects in fragmentation of diastereoisomers of protected diethyl 1,2-diamino-alkylphosphonates.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2010, v. 24, n. 16, p. 2324, doi. 10.1002/rcm.4644
- By:
- Publication type:
- Article
A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.703465
- By:
- Publication type:
- Article